AAAAAA
Results:
1-10
|
Results: 10
Authors:
Nicacio, CD
Williamson, RA
Parren, PWHI
Lundkvist, A
Burton, DR
Bjorling, E
Citation: Cd. Nicacio et al., Neutralizing human Fab fragments against measles virus recovered by phage display, J VIROLOGY, 76(1), 2002, pp. 251-258
Authors:
Rytting, AS
Akerblom, L
Albert, J
Unge, T
Bjorling, E
Al-Khalili, L
Gronowitz, JS
Kallander, CFR
Citation: As. Rytting et al., Monoclonal antibodies to native HIV type 1 reverse transcriptase and theirinteraction with enzymes from different subtypes, AIDS RES H, 16(13), 2000, pp. 1281-1294
Authors:
Ehnlund, M
Bjorling, E
Citation: M. Ehnlund et E. Bjorling, Fine characterization of the antigenic site within the flap region in the protease protein of HIV-1, ARCH VIROL, 145(2), 2000, pp. 365-369
Authors:
Nicacio, CD
Lundkvist, A
Sjolander, KB
Plyusnin, A
Salonen, EM
Bjorling, E
Citation: Cd. Nicacio et al., A neutralizing recombinant human antibody Fab fragment against Puumala hantavirus, J MED VIROL, 60(4), 2000, pp. 446-454
Authors:
Nicacio, CD
Bjorling, E
Lundkvist, A
Citation: Cd. Nicacio et al., Immunoglobulin A responses to Puumala hantavirus, J GEN VIROL, 81, 2000, pp. 1453-1461
Authors:
Skott, P
Lucht, E
Julander, I
Dillner, J
Bjorling, E
Citation: P. Skott et al., Salivary sIgA response in HIV-1 infection, J ACQ IMM D, 21(2), 1999, pp. 73-80
Authors:
Skott, P
Achour, A
Norin, M
Thorstensson, R
Bjorling, E
Citation: P. Skott et al., Characterization of neutralizing sites in the second variable and fourth variable region in gp125 and a conserved region in gp36 of human immunodeficiency virus type 2, VIRAL IMMUN, 12(1), 1999, pp. 79-88
Authors:
Morner, A
Achour, A
Norin, M
Thorstensson, R
Bjorling, E
Citation: A. Morner et al., Fine characterization of a V3-region neutralizing epitope in human immunodeficiency virus type 2, VIRUS RES, 59(1), 1999, pp. 49-60
Authors:
Morner, A
Bjorndal, A
Albert, J
Kewalramani, VN
Littman, DR
Inoue, R
Thorstensson, R
Fenyo, EM
Bjorling, E
Citation: A. Morner et al., Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage, J VIROLOGY, 73(3), 1999, pp. 2343-2349
Authors:
Bjorling, E
von Garrelts, E
Morner, A
Ehnlund, M
Persson, MAA
Citation: E. Bjorling et al., Human neutralizing human immunodeficiency virus type 2-specific Fab molecules generated by phage display, J GEN VIROL, 80, 1999, pp. 1987-1993
Risultati:
1-10
|